These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37580110)

  • 1. Annals of the Rheumatic Diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers.
    Pisetsky DS
    Ann Rheum Dis; 2023 Oct; 82(10):1243-1247. PubMed ID: 37580110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification.
    Pisetsky DS
    Scand J Immunol; 2012 Sep; 76(3):223-8. PubMed ID: 22670594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of autoantibodies in systemic rheumatic diseases.
    Fritzler MJ
    Mol Biol Rep; 1996; 23(3-4):133-45. PubMed ID: 9112221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases.
    Elnady BM; Kamal NM; Shaker RHM; Soliman AF; Hasan WA; Alghamdi HA; Algethami MM; Jajah MB
    Medicine (Baltimore); 2016 Sep; 95(38):e4336. PubMed ID: 27661011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging technologies in autoantibody testing for rheumatic diseases.
    Olsen NJ; Choi MY; Fritzler MJ
    Arthritis Res Ther; 2017 Jul; 19(1):172. PubMed ID: 28738887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral autoimmunity in systemic rheumatic disease. A review.
    Bernstein RM
    J R Coll Physicians Lond; 1990 Jan; 24(1):18-25. PubMed ID: 2407838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.
    Steiner G; Skriner K; Smolen JS
    Int Arch Allergy Immunol; 1996 Dec; 111(4):314-9. PubMed ID: 8957102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of autoantibody testing.
    Aggarwal A
    Best Pract Res Clin Rheumatol; 2014 Dec; 28(6):907-20. PubMed ID: 26096093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of autoantibodies in HIV infection.
    Massabki PS; Accetturi C; Nishie IA; da Silva NP; Sato EI; Andrade LE
    AIDS; 1997 Dec; 11(15):1845-50. PubMed ID: 9412703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
    Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody Biomarkers in Rheumatic Diseases.
    Kang EH; Ha YJ; Lee YJ
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatic disease among Oklahoma tribal populations: a cross-sectional study.
    Gaddy JR; Vista ES; Robertson JM; Dedeke AB; Roberts VC; Klein WS; Levin JH; Mota FH; Cooper TM; Grim GA; Khan S; James JA
    J Rheumatol; 2012 Oct; 39(10):1934-41. PubMed ID: 22896022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic Disease Autoantibodies in Patients with Autoimmune Thyroid Diseases.
    Nisihara R; Pigosso YG; Prado N; Utiyama SRR; De Carvalho GA; Skare TL
    Med Princ Pract; 2018; 27(4):332-336. PubMed ID: 29864750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
    Breda L; Nozzi M; De Sanctis S; Chiarelli F
    Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in the diagnosis of systemic rheumatic diseases.
    von Mühlen CA; Tan EM
    Semin Arthritis Rheum; 1995 Apr; 24(5):323-58. PubMed ID: 7604300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis.
    Mahmud SA; Binstadt BA
    Front Immunol; 2018; 9():3168. PubMed ID: 30693002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases.
    Skriner K; Hueber W; Süleymanoglu E; Höfler E; Krenn V; Smolen J; Steiner G
    Arthritis Rheum; 2008 Feb; 58(2):511-20. PubMed ID: 18240226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA; Bauer O; Seelig HP
    Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.